These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21051911)

  • 1. A critical need to reconsider cancer trial eligibility requirements.
    Markman M
    Oncology; 2010; 79(1-2):1-2. PubMed ID: 21051911
    [No Abstract]   [Full Text] [Related]  

  • 2. Rethinking trial eligibility in the NCD era.
    Lancet Oncol; 2015 Mar; 16(3):233. PubMed ID: 25752544
    [No Abstract]   [Full Text] [Related]  

  • 3. Eligibility exclusions, losses to follow-up, removal of randomized patients, and uncounted events in cancer clinical trials.
    Gail MH
    Cancer Treat Rep; 1985 Oct; 69(10):1107-13. PubMed ID: 4042091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer clinical trials in the USA: patient eligibility, generalizability of results and technology transfer.
    Begg CB
    Bull Cancer; 1987; 74(2):197-203. PubMed ID: 3607303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion for protocol eligibility.
    Callum JL; Henry B; Lin Y
    N Engl J Med; 2010 Oct; 363(17):1681-2. PubMed ID: 20961259
    [No Abstract]   [Full Text] [Related]  

  • 6. Reevaluating Eligibility Criteria - Balancing Patient Protection and Participation in Oncology Trials.
    Beaver JA; Ison G; Pazdur R
    N Engl J Med; 2017 Apr; 376(16):1504-1505. PubMed ID: 28423289
    [No Abstract]   [Full Text] [Related]  

  • 7. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials.
    Kornblith AB; Kemeny M; Peterson BL; Wheeler J; Crawford J; Bartlett N; Fleming G; Graziano S; Muss H; Cohen HJ;
    Cancer; 2002 Sep; 95(5):989-96. PubMed ID: 12209681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Never too old? Age should not be a barrier to enrollment in cancer clinical trials.
    Aapro MS; Köhne CH; Cohen HJ; Extermann M
    Oncologist; 2005 Mar; 10(3):198-204. PubMed ID: 15793223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity as a focus of clinical cancer trials: an important unmet need.
    Markman M
    Oncology; 2007; 73(5-6):279-80. PubMed ID: 18477852
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trial accrual among new cancer patients at a community-based cancer center.
    Go RS; Frisby KA; Lee JA; Mathiason MA; Meyer CM; Ostern JL; Walther SM; Schroeder JE; Meyer LA; Umberger KE
    Cancer; 2006 Jan; 106(2):426-33. PubMed ID: 16353206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to clinical trial participation by older women with breast cancer.
    Kemeny MM; Peterson BL; Kornblith AB; Muss HB; Wheeler J; Levine E; Bartlett N; Fleming G; Cohen HJ
    J Clin Oncol; 2003 Jun; 21(12):2268-75. PubMed ID: 12805325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to clinical trial enrollment: are state mandates the solution?
    Hillner BE
    J Natl Cancer Inst; 2004 Jul; 96(14):1048-9. PubMed ID: 15265958
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trial accrual efforts: some progress amid ongoing debate.
    McNeil C
    J Natl Cancer Inst; 2004 Oct; 96(19):1417-8. PubMed ID: 15467029
    [No Abstract]   [Full Text] [Related]  

  • 14. Geriatric oncology aims for clinical trials.
    Sinha G
    J Natl Cancer Inst; 2006 Nov; 98(21):1516-8. PubMed ID: 17077352
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trials in oncology and elderly patients].
    Moncenix G
    Soins Gerontol; 2003; (44):39. PubMed ID: 14648943
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial design in oncology: protocol design.
    Sullivan R
    Lancet Oncol; 2004 Dec; 5(12):759. PubMed ID: 15581549
    [No Abstract]   [Full Text] [Related]  

  • 17. Roundtable discussion. Investigational exclusion, clinical trials, and cancer.
    Goodman C
    Oncology (Williston Park); 1998 Nov; 12(11A):37-49. PubMed ID: 10028502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third party reimbursement for participation in cancer clinical trials: a proposal for legislation.
    Plaue GM
    J Contemp Health Law Policy; 2000; 16(2):305-54. PubMed ID: 10921232
    [No Abstract]   [Full Text] [Related]  

  • 19. Arizona's cancer clinical trials law: flawed process, flawed product.
    Olson-Garewal JK; Hessler K
    Hastings Cent Rep; 2001; 31(3):22-4. PubMed ID: 11478120
    [No Abstract]   [Full Text] [Related]  

  • 20. [Entering of patients in clinical-oncological trials: why not exclusive exclusion when inclusion is out of the question?].
    Kiebert GM; van de Velde CJ
    Ned Tijdschr Geneeskd; 1995 Feb; 139(7):320-4. PubMed ID: 7877700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.